Navigation Links
New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema
Date:1/11/2008

SKILLMAN, N.J., Jan. 11 /PRNewswire/ -- According to the American Academy of Dermatology (AAD), 10-20 percent of the world's population suffers from eczema, an inflamed skin condition characterized by red, scaly and itchy skin. To help manage the condition's symptoms, which tend to flare up in the winter months, AVEENO(R), the leader in ACTIVE NATURALS(R), has introduced the Eczema Care Moisturizing Cream and Body Wash, formulated with hydrating ingredients to help manage the daily symptoms of eczema and improve the skin's natural barrier function.

The AVEENO(R) Eczema Care products were developed with leading dermatologists and pediatric dermatologists to offer mild formulas suitable for both adults and babies, that are perfect for everyday use. AVEENO(R) Eczema Care products are specially formulated with Natural Colloidal Oatmeal and Pure Oat Essence to help lock moisture into the skin and soothe symptoms such as red, irritated and itchy skin. Additionally, the Moisturizing Cream includes a patented Triple Oat formula of key ingredients to help maintain the skin's barrier and provide moisturization for a full 24 hours. The products are also steroid free.

"We have conducted extensive research in order to develop this proprietary Triple Oat formula to manage eczema symptoms," says Judith Nebus, manager of clinical research for skin care at AVEENO(R). "Key ingredients in the patented formula, including Ceramides and Panthenol, moisturize and help protect the skin's barrier to help prevent the recurrence of redness, irritation and extra dry skin."

In a clinical study, 100% of subjects who used the AVEENO(R) Eczema Care Moisturizing Cream twice a day showed improvement in roughness in one week. In a separate clinical study, subjects who used the AVEENO(R) Eczema Care products showed significant improvements in itching and skin scaling after one week of use.

Additionally, 89% of consumers found that the Moisturizing Cream helped them manage the daily symptoms of eczema and 78% of consumers reported the same for the Body Wash.(1)

In addition to the positive consumer response, the AVEENO(R) Eczema Care Body Wash and Moisturizing Cream have been awarded the National Eczema Association Seal of Acceptance. The National Eczema Association (NEA) recognizes the important role of specially formulated cleansers and moisturizers in the management of eczema symptoms. Additionally, both the AVEENO(R) Eczema Care Body Wash and Moisturizing Cream won an Allure "Best Beauty Breakthrough" Award in the magazine's Beauty Awards that appeared in the October issue.

The AVEENO(R) Eczema Care Body Wash is available for $9.99 for a 10 oz. bottle and the AVEENO(R) Eczema Care Moisturizing Cream is available for $9.99 for a 6 oz. bottle with other itch relief products in the First Aid aisle at Target, CVS, Walgreens, Safeway, Wegmans, Kmart, Bed Bath & Beyond and Drugstore.com.

About AVEENO(R):

AVEENO(R), one of the brands of the Johnson & Johnson Consumer Products Company, is the leader in ACTIVE NATURALS(R) technology, including Oatmeal, Soy, Shiitake Mushrooms and Feverfew. Recommended by dermatologists and pediatricians for over 60 years, the brand is committed to developing breakthrough product formulations with new and existing natural ingredients that are clinically proven to deliver real skincare benefits. The AVEENO(R) line includes skincare products for face, body, baby and sun protection. For more information about the AVEENO(R) brand and its product offerings, visit: http://www.aveeno.com.

(1) AVEENO(R) Consumer Usage Study, January 2007

(C)JOHNSON & JOHNSON Consumer Companies, Inc. 2007


'/>"/>
SOURCE AVEENO(R)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Positive Results Published Using AtriCure Minimally Invasive Products
2. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
3. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
4. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
5. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
6. FDA Confirms Seizure of Eyelash Product Was Not Prompted by Reports of Adverse Effects
7. Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
Breaking Medicine News(10 mins):